谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials.

The oncologist(2023)

引用 0|浏览48
暂无评分
关键词
MEK inhibitor,SHR7390,anti-PD-1,camrelizumab,colorectal cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要